[en] Purpose
Recent studies have suggested that metabolic factors (obesity, diabetes, hypertension and dyslipidemia) and their clustering in metabolic syndrome (MetS) might be involved in the pathophysiology of knee osteoarthritis (OA). We investigated their impact on radiographic progression by an annualised measure of the joint space narrowing (JSN) of the medial tibiofemoral compartment.
Methods
559 patients older than 50 years with symptomatic knee OA were recruited for the placebo arm of the SEKOIA trial. The presence of diabetes, hypertension and dyslipidemia was determined at baseline interview. BMI was calculated, obesity was considered >30 kg/m2. MetS was defined by the sum of metabolic factors ≥3. Minimal medial tibiofemoral joint space on plain radiographs was measured by an automated method at baseline and then annually for up to 3 years.
Results
The mean age of patients was 62.8 [62.2-63.4] years; 392 were women. A total of 43.8% was obese, 6.6% had type 2 diabetes, 45.1% hypertension, 27.6% dyslipidemia and 13.6% MetS. Mean annualised JSN was greater for patients with type 2 diabetes than without diabetes (0.26 [-0.35 - -0.17] vs. 0.14 [-0.16 - -0.12] mm; p=0.001). This association remained significant after adjustment for sex, age, BMI, hypertension and dyslipidemia (p=0.018). In subgroup analysis, type 2 diabetes was a significant predictor of JSN in males but not females. The other metabolic factors and MetS were not associated with annualised JSN.
Conclusion
Type 2 diabetes was a predictor of joint space reduction in men with established knee OA. No relationships were found between MetS or other metabolic factors and radiographic progression.
Disciplines :
General & internal medicine
Author, co-author :
Eymard, F
Parsons, C
Edwards, M
Petit-Dop, F
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Richette, P
Cooper, C
Chevalier, X
Language :
English
Title :
Diabetes is a risk factor for knee osteoarthritis progression
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Pereira D., Peleteiro B., Araújo J., Branco J., Santos R.A., Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011, 19:1270-1285.
Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
Picavet H.S.J., Hazes J.M.W. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis 2003, 62:644-650.
Blagojevic M., Jinks C., Jeffery A., Jordan K.P. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010, 18:24-33.
Cooper C., Snow S., McAlindon T.E., Kellingray S., Stuart B., Coggon D., et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000, 43:995-1000.
Prieto-Alhambra D., Judge A., Javaid M.K., Cooper C., Diez-Perez A., Arden N.K. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis 2014, 73:1659-1664.
Felson D.T., Zhang Y., Hannan M.T., Naimark A., Weissman B., Aliabadi P., et al. Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 1997, 40:728-733.
Suri P., Morgenroth D.C., Hunter D.J. Epidemiology of osteoarthritis and associated comorbidities. PM R 2012, 4:S10-S19.
Yusuf E., Nelissen R.G., Ioan-Facsinay A., Stojanovic-Susulic V., DeGroot J., van Osch G., et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 2010, 69:761-765.
Sowers M., Karvonen-Gutierrez C.A., Palmieri-Smith R., Jacobson J.A., Jiang Y., Ashton-Miller J.A. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum 2009, 61:1328-1336.
Lawrence J.S. Hypertension in relation to musculoskeletal disorders. Ann Rheum Dis 1975, 34:451-456.
Stürmer T., Sun Y., Sauerland S., Zeissig I., Günther K.P., Puhl W., et al. Serum cholesterol and osteoarthritis. The baseline examination of the Ulm Osteoarthritis Study. JRheumatol 1998, 25:1827-1832.
Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. JRheumatol 1995, 22:1118-1123.
Cimmino M.A., Cutolo M. Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol 1990, 8:251-257.
Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
Alberti K.G.M.M., Zimmet P., Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:2045-2051.
Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
Inoue R., Ishibashi Y., Tsuda E., Yamamoto Y., Matsuzaka M., Takahashi I., et al. Medical problems and risk factors of metabolic syndrome among radiographic knee osteoarthritis patients in the Japanese general population. JOrthop Sci 2011, 16:704-709.
Puenpatom R.A., Victor T.W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009, 121:9-20.
Han C.D., Yang I.H., Lee W.S., Park Y.J., Park K.K. Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES). BMC Public Health 2013, 13:603.
Karvonen-Gutierrez C.A., Sowers M.R., Heeringa S.G. Sex dimorphism in the association of cardiometabolic characteristics and osteophytes-defined radiographic knee osteoarthritis among obese and non-obese adults: NHANES III. Osteoarthritis Cartilage 2012 Jul, 20(7):614-621.
Yoshimura N., Muraki S., Oka H., Tanaka S., Kawaguchi H., Nakamura K., et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012, 20:1217-1226.
Monira Hussain S., Wang Y., Cicuttini F.M., Simpson J.A., Giles G.G., Graves S., et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study. Semin Arthritis Rheum 2014, 43:429-436.
Schett G., Kleyer A., Perricone C., Sahinbegovic E., Iagnocco A., Zwerina J., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 2013, 36:403-409.
Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
Felson D.T., Niu J., Guermazi A., Sack B., Aliabadi P. Defining radiographic incidence and progression of knee osteoarthritis: suggested modifications of the Kellgren and Lawrence scale. Ann Rheum Dis 2011, 70:1884-1886.
Ornetti P., Brandt K., Hellio-Le Graverand M.-P., Hochberg M., Hunter D.J., Kloppenburg M., et al. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 2009, 17:856-863.
Reginster J.-Y., Badurski J., Bellamy N., Bensen W., Chapurlat R., Chevalier X., et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013, 72:179-186.
Cooper C., Reginster J.-Y., Chapurlat R., Christiansen C., Genant H., Bellamy N., et al. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Curr Med Res Opin 2012, 28:231-239.
Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049.
Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. JRheumatol 1988, 15:1833-1840.
Kothari M., Guermazi A., von Ingersleben G., Miaux Y., Sieffert M., Block J.E., et al. Fixed-flexion radiography of the knee provides reproducible joint space width measurements in osteoarthritis. Eur Radiol 2004, 14:1568-1573.
Gensburger D., Arlot M., Sornay-Rendu E., Roux J.-P., Delmas P. Radiologic assessment of age-related knee joint space changes in women: a 4-year longitudinal study. Arthritis Rheum 2009, 61:336-343.
Gensburger D., Roux J.-P., Arlot M., Sornay-Rendu E., Ravaud P., Chapurlat R. Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res 2010, 62:1699-1705.
Botha-Scheepers S., Watt I., Breedveld F.C., Kloppenburg M. Reading radiographs in pairs or in chronological order influences radiological progression in osteoarthritis. Rheumatology 2005, 44:1452-1455.
Felson D.T., Nevitt M.C. Blinding images to sequence in osteoarthritis: evidence from other diseases. Osteoarthritis Cartilage 2009, 17:281-283.
Eyre D.R., Weis M.A., Wu J.-J. Articular cartilage collagen: an irreplaceable framework?. Eur Cell Mater 2006, 12:57-63.
Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002, 46:114-123.
Chen Y.J., Sheu M.L., Tsai K.S., Yang R.S., Liu S.H. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products. PloS One 2013, 8:e66611.
Steenvoorden M.M.C., Huizinga T.W.J., Verzijl N., Bank R.A., Ronday H.K., Luning H.A.F., et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006, 54:253-263.
Rosa S.C., Gonçalves J., Judas F., Mobasheri A., Lopes C., Mendes A.F. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 2009, 11:R80.
Selvin E., Halushka M.K., Rawlings A.M., Hoogeveen R.C., Ballantyne C.M., Coresh J., et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013, 62:2116-2121.
Schalkwijk C.G., Stehouwer C.D.A. Comment on: Selvin etal. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121. Diabetes 2013, 62:e25.
Yamagishi S. Comment on: Selvin etal. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116-2121. Diabetes 2013, 62:e26.
Penno G., Solini A., Bonora E., Fondelli C., Orsi E., Zerbini G., et al. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. JIntern Med 2013, 274:176-191.
Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes 1988, 37:476-481.
Rasul S., Ilhan A., Wagner L., Luger A., Kautzky-Willer A. Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: greater effects in male patients. Gend Med 2012, 9:187-196.
Bruun C., Siersma V., Guassora A.D., Holstein P., de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med 2013, 30:964-972.
Aaberg M.L., Burch D.M., Hud Z.R., Zacharias M.P. Gender differences in the onset of diabetic neuropathy. JDiabetes Complicat 2008, 22:83-87.
Booya F., Bandarian F., Larijani B., Pajouhi M., Nooraei M., Lotfi J. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol 2005, 5:24.
Leaverton P.E., Peregoy J., Fahlman L., Sangeorzan E., Barrett J.P. Does diabetes hide osteoarthritis pain?. Med Hypotheses 2012, 78:471-474.
Riddle D.L., Jiranek W.A. Knee osteoarthritis radiographic progression and associations with pain and function prior to knee arthroplasty: a multicenter comparative cohort study. Osteoarthritis Cartilage 2015, 23:391-396.
Karsdal M., Bihlet A., Byrjalsen I., Alexandersen P., Ladel C., Michaels M., et al. OA phenotypes, rather than disease stage, drive structural progression - identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. Osteoarthritis Cartilage 2015, 23:550-558.
Schouten J.S., van den Ouweland F.A., Valkenburg H.A. A12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992, 51:932-937.
Yusuf E., Bijsterbosch J., Slagboom P.E., Rosendaal F.R., Huizinga T.W.J., Kloppenburg M. Body mass index and alignment and their interaction as risk factors for progression of knees with radiographic signs of osteoarthritis. Osteoarthritis Cartilage 2011, 19:1117-1122.
Reijman M., Pols H.A.P., Bergink A.P., Hazes J.M.W., Belo J.N., Lievense A.M., et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007, 66:158-162.
Niu J., Zhang Y.Q., Torner J., Nevitt M., Lewis C.E., Aliabadi P., et al. Is obesity a risk factor for progressive radiographic knee osteoarthritis?. Arthritis Rheum 2009, 61:329-335.
Le Graverand M.-P.H., Brandt K., Mazzuca S.A., Raunig D., Vignon E. Progressive increase in body mass index is not associated with a progressive increase in joint space narrowing in obese women with osteoarthritis of the knee. Ann Rheum Dis 2009, 68:1734-1738.
Felson D.T., Goggins J., Niu J., Zhang Y., Hunter D.J. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 2004, 50:3904-3909.
Brouwer G.M., van Tol A.W., Bergink A.P., Belo J.N., Bernsen R.M.D., Reijman M., et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum 2007, 56:1204-1211.
Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003, 29:526-532.
Herrero-Beaumont G., Roman-Blas J.A., Largo R., Berenbaum F., Castañeda S. Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis. Ann Rheum Dis 2011, 70:1523-1525.
Lin W., Alizai H., Joseph G.B., Srikhum W., Nevitt M.C., Lynch J.A., et al. Physical activity in relation to knee cartilage T2 progression measured with 3 T MRI over a period of 4 years: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2013, 21:1558-1566.
Chiarelli F., de Martino M., Mezzetti A., Catino M., Morgese G., Cuccurullo F., et al. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. JPediatr 1999, 134:486-491.
Beisswenger P.J., Moore L.L., Curphey T.J. Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes. Diabetes Care 1993, 16:689-694.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
